{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:16:21Z","timestamp":1745381781217,"version":"3.40.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,22]]},"DOI":"10.7759\/cureus.82784","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T13:50:16Z","timestamp":1745329816000},"source":"Crossref","is-referenced-by-count":0,"title":["Dilemmas and Challenges in the Anesthetic Management of Liver Transplantation for Transthyretin Amyloidosis in the Asian Context: A Case Report"],"prefix":"10.7759","author":[{"given":"Jacklyn","family":"Yek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffi","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sook Muay","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selene","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000092307.98347.CB","article-title":"Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry","volume":"77","author":"Herlenius G","year":"2004","unstructured":"Herlenius G, Wilczek HE, Larsson M, Ericzon BG. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation. 2004, 77:64-71. 10.1097\/01.TP.0000092307.98347.CB","journal-title":"Transplantation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz MA","year":"2015","unstructured":"Gertz MA, Benson MD, Dyck PJ, et al.. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015, 66:2451-66. 10.1016\/j.jacc.2015.09.075","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.7.1057","article-title":"Transthyretin-related familial amyloidotic polyneuropathy","volume":"62","author":"Ando Y","year":"2005","unstructured":"Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol. 2005, 62:1057-62. 10.1001\/archneur.62.7.1057","journal-title":"Arch Neurol"},{"key":"ref4","unstructured":"VYNDAQEL- tafamidis meglumine capsule, liquid filled; VYNDAMAX- tafamidis capsule, liquid filled. (2023). Accessed. July 29, 2024: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=11685."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182115bc1","article-title":"Acute amiodarone hepatotoxicity after liver transplantation","volume":"91","author":"von Vital JM","year":"2011","unstructured":"von Vital JM, Karachristos A, Singhal A, Thomas R, Jain A. Acute amiodarone hepatotoxicity after liver transplantation. Transplantation. 2011, 91:e62-4. 10.1097\/TP.0b013e3182115bc1","journal-title":"Transplantation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2011.574354072","article-title":"Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR)","volume":"18 Suppl 1","author":"Wilczek HE","year":"2011","unstructured":"Wilczek HE, Larsson M, Ericzon BG. Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR). Amyloid. 2011, 18 Suppl 1:193-5. 10.3109\/13506129.2011.574354072","journal-title":"Amyloid"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3233\/JND-210656","article-title":"Hereditary transthyretin amyloidosis- clinical and genetic characteristics of a multiracial South-East Asian cohort in Singapore","volume":"8","author":"Chen Z","year":"2021","unstructured":"Chen Z, Koh JS, Saini M, et al.. Hereditary transthyretin amyloidosis- clinical and genetic characteristics of a multiracial South-East Asian cohort in Singapore. J Neuromuscul Dis. 2021, 8:723-33. 10.3233\/JND-210656","journal-title":"J Neuromuscul Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23882","article-title":"Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia","volume":"45","author":"Lin W","year":"2022","unstructured":"Lin W, Chattranukulchai P, Lee AP, Lin YH, Yu WC, Liew HB, Oomman A. Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia. Clin Cardiol. 2022, 45:898-907. 10.1002\/clc.23882","journal-title":"Clin Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ea15d4","article-title":"Progression of transthyretin amyloid neuropathy after liver transplantation","volume":"75","author":"Liepnieks JJ","year":"2010","unstructured":"Liepnieks JJ, Zhang LQ, Benson MD. Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology. 2010, 75:324-7. 10.1212\/WNL.0b013e3181ea15d4","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2018.07.326","article-title":"Progressive cardiomyopathy in TTR amyloidosis after liver transplant","volume":"24","author":"Kay J","year":"2018","unstructured":"Kay J, Menachem J, O\u2019Quinn R, Drachman B. Progressive cardiomyopathy in TTR amyloidosis after liver transplant. J Card Fail. 2018, 24:81. 10.1016\/j.cardfail.2018.07.326","journal-title":"J Card Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartjsupp\/suac104","article-title":"The treatment of amyloidosis is being refined","volume":"24","author":"Cantone A","year":"2022","unstructured":"Cantone A, Sanguettoli F, Dal Passo B, Serenelli M, Rapezzi C. The treatment of amyloidosis is being refined. Eur Heart J Suppl. 2022, 24:I131-8. 10.1093\/eurheartjsupp\/suac104","journal-title":"Eur Heart J Suppl"},{"key":"ref12","unstructured":"Tafamidis for treating transthyretin amyloid cardiomyopathy. Technology Guidance from the MOH Drug Advisory Committee. (2024). Accessed. 29 July: https:\/\/isomer-user-content.by.gov.sg\/68\/9cdf81e8-3377-4fb3-8b53-033f510f7305\/tafamidis-for-treating-transthyretin-am...."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200003000-00036","article-title":"Fatal perioperative myocardial infarction in four patients with cardiac amyloidosis","volume":"92","author":"Kotani N","year":"2000","unstructured":"Kotani N, Hashimoto H, Muraoka M, Kabara S, Okawa H, Matsuki A. Fatal perioperative myocardial infarction in four patients with cardiac amyloidosis. Anesthesiology. 2000, 92:873-5. 10.1097\/00000542-200003000-00036","journal-title":"Anesthesiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/lv.2000.6145","article-title":"Liver transplantation for hereditary transthyretin amyloidosis","volume":"6","author":"Suhr OB","year":"2000","unstructured":"Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl. 2000, 6:263-76. 10.1053\/lv.2000.6145","journal-title":"Liver Transpl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1986.tb02422.x","article-title":"Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia","volume":"30","author":"Eriksson P","year":"1986","unstructured":"Eriksson P, Boman K, Jacobsson B, Olofsson BO. Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia. Acta Anaesthesiol Scand. 1986, 30:317-20. 10.1111\/j.1399-6576.1986.tb02422.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-019-00517-y","article-title":"Pacemaker implantation in familial amyloid polyneuropathy: when and for whom?","volume":"55","author":"Milner J","year":"2019","unstructured":"Milner J, Teixeira RN, Marinho AV, et al.. Pacemaker implantation in familial amyloid polyneuropathy: when and for whom?. J Interv Card Electrophysiol. 2019, 55:207-11. 10.1007\/s10840-019-00517-y","journal-title":"J Interv Card Electrophysiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson MM","year":"2020","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV, et al.. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2020, 142:e7-e22. 10.1161\/CIR.0000000000000792","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk RH","year":"2005","unstructured":"Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005, 112:2047-60. 10.1161\/CIRCULATIONAHA.104.489187","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.05.071","article-title":"Current status of liver transplantation in Asia","volume":"82S","author":"Hibi T","year":"2020","unstructured":"Hibi T, Wei Chieh AK, Chi-Yan Chan A, Bhangui P. Current status of liver transplantation in Asia. Int J Surg. 2020, 82S:4-8. 10.1016\/j.ijsu.2020.05.071","journal-title":"Int J Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13443","article-title":"Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature","volume":"8","author":"Adam RD","year":"2021","unstructured":"Adam RD, Coriu D, Jercan A, B\u0103deli\u0163\u0103 S, Popescu BA, Damy T, Jurcu\u0163 R. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature. ESC Heart Fail. 2021, 8:2380-96. 10.1002\/ehf2.13443","journal-title":"ESC Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/338838-dilemmas-and-challenges-in-the-anesthetic-management-of-liver-transplantation-for-transthyretin-amyloidosis-in-the-asian-context-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T13:50:17Z","timestamp":1745329817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/338838-dilemmas-and-challenges-in-the-anesthetic-management-of-liver-transplantation-for-transthyretin-amyloidosis-in-the-asian-context-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.82784","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,22]]}}}